• Search History (Register)
  • MeSH Browser
  • [Clear]
    • Canada

Welcome to the international HTA database


Showing [3276 Records] Selected Records [0 Hits] [Clear]
Year Source Title
2020     Ontario Health Automated CT perfusion imaging to aid in the selection of patients with acute ischemic stroke for mechanical thrombectomy
2020     Ontario Health Transcatheter Aortic Valve Implantation in Patients With Severe Aortic Valve Stenosis at Low Surgical Risk
2020     Ontario Health Genome-Wide Sequencing for Unexplained Developmental Disabilities or Multiple Congenital Anomalies: A Health Technology Assessment
2020     Ontario Health Gene Expression Profiling Tests for Early-Stage Invasive Breast Cancer: A Health Technology Assessment
2020     Ontario Health 5-Aminolevulinic Acid Hydrochloride (5 ALA)–Guided Surgical Resection of High-Grade Gliomas: A Health Technology Assessment
2020     Ontario Health Extracorporeal Membrane Oxygenation for Cardiac Indications in Adults: A Health Technology Assessment
2020     Ontario Health Continual Long-Term Physiotherapy After Stroke: A Health Technology Assessment
2020     Ontario Health 10-kHz high-frequency spinal cord stimulation for adults with chronic noncancer pain: a health technology assessment
2020     Ontario Health Cell-Free Circulating Tumour DNA Blood Testing to Detect EGFR T790M Mutation in People With Advanced Non–Small Cell Lung Cancer: A Health Technology Assessment
2020     Ontario Health Auditory Brainstem Implantation for Adults With Neurofibromatosis 2 or Severe Inner Ear Abnormalities: A Health Technology Assessment
2020     Ontario Health Portable Normothermic Cardiac Perfusion System in Donation After Cardiocirculatory Death: A Health Technology Assessment
2020     Ontario Health Transcatheter Aortic Valve Implantation in Patients With Severe, Symptomatic Aortic Valve Stenosis at Intermediate Surgical Risk: A Health Technology Assessment
2020     Ontario Health Implantable devices for single-sided deafness and conductive or mixed hearing loss: a health technology assessment
2020     Institut national d'excellence en sante et en services sociaux (INESSS) [Portrait of coronary revascularization by percutaneous coronary intervention and coronary bypass grafting in Quebec, 2015-2018]
2019     Institut universitaire de cardiologie et de pneumologie de Québec – Université Laval (IUCPQ-ULaval) [Evaluation of the effectiveness and cost effectiveness of cardiac rehabilitation programs]
2019     Institut universitaire de cardiologie et de pneumologie de Québec – Université Laval (IUCPQ-ULaval) [Induction immunosuppressive therapy in patients undergoing heart transplantation]
2019     Institut universitaire de cardiologie et de pneumologie de Québec – Université Laval (IUCPQ-ULaval) [Measurement of gastric residual volume during enteral feeding in patients hospitalized in the intensive care unit]
2019     Institut universitaire de cardiologie et de pneumologie de Québec – Université Laval (IUCPQ-ULaval) [Use of incentive spirometry for the prevention of pulmonary complications following surgery]
2019     Canadian Agency for Drugs and Technologies in Health (CADTH) Flash glucose monitoring system for people with type 1 or type 2 diabetes: a health technology assessment
2019     Canadian Agency for Drugs and Technologies in Health (CADTH) Genome-wide sequencing: ethical considerations
2019     Canadian Agency for Drugs and Technologies in Health (CADTH) Axicabtagene ciloleucel for large B-cell lymphoma: clinical report
2019     Canadian Agency for Drugs and Technologies in Health (CADTH) Internet-delivered cognitive behavioural therapy for major depressive disorder and anxiety disorders: a health technology assessment
2019     Canadian Agency for Drugs and Technologies in Health (CADTH) HPV testing for primary cervical cancer screening: a health technology assessment
2019     Canadian Agency for Drugs and Technologies in Health (CADTH) Community water fluoridation programs: a health technology assessment - review of dental caries and other health outcomes
2019     Canadian Agency for Drugs and Technologies in Health (CADTH) Dual antiplatelet therapy following percutaneous coronary intervention: clinical and economic impact of standard versus extended duration
2019     Canadian Agency for Drugs and Technologies in Health (CADTH) Optimal use of minimally invasive glaucoma surgery: a health technology assessment
2019     Canadian Agency for Drugs and Technologies in Health (CADTH) Tisagenlecleucel for acute lymphoblastic leukemia and diffuse large b-cell lymphoma: clinical report
2019     Centre intégré universitaire de santé et de services sociaux de la Capitale-Nationale (CIUSSS) [Identification of psychosocial practices and interventions that support the adaptation and rehabilitation of adults with Prader-Willi Syndrome]
2019     Institut national d'excellence en sante et en services sociaux (INESSS) [Report: best strategies for reducing the risk of severe toxicities caused by dihydropyrimidine dehydrogenase deficiency]
2019     Institut national d'excellence en sante et en services sociaux (INESSS) [Optimal use guide: pharmacological treatment of sexually transmitted and blood-borne infections ─ external condylomas (anogenital warts)]
2019     Institut national d'excellence en sante et en services sociaux (INESSS) [Report: treatment of mitral regurgitation by a percutaneous device with clip (TMVRc)]
2019     Institut national d'excellence en sante et en services sociaux (INESSS) [Report: breast tomosynthesis and breast cancer screening]
2019     Institut national d'excellence en sante et en services sociaux (INESSS) [Report: tisagenlecleucel for the treatment of relapsed or refractory B-cell acute lymphoblastic leukemia]
2019     Institut national d'excellence en sante et en services sociaux (INESSS) [Report: tisagenlecleucel for the treatment of relapsed or refractory diffuse large B-cell lymphoma]
2019     Institut national d'excellence en sante et en services sociaux (INESSS) [State of knowledge: approach to managing access to cancer care: a review of the literature and practices]
2019     Institut national d'excellence en sante et en services sociaux (INESSS) [Report: The Argus II retinal implant]
2019     Institut national d'excellence en sante et en services sociaux (INESSS) [National medical protocols and associated prescriptions: acute exacerbation of chronic obstructive pulmonary disease]
2019     Institut national d'excellence en sante et en services sociaux (INESSS) [Report: use of linear accelerators with on-board magnetic resonance imaging (MRI) for real-time MRI-guided radiation therapy treatments]
2019     Institut national d'excellence en sante et en services sociaux (INESSS) [Report: use of extracorporeal membrane oxygenation (ECMO) in adults in Quebec]
2019     Institut national d'excellence en sante et en services sociaux (INESSS) [State of knowledge: use of rifapentine in the treatment of latent tuberculosis infection]
2019     Institut national d'excellence en sante et en services sociaux (INESSS) [Guidelines and standards: respiratory multiplex NAAT (8 or more targets)]
2019     Institut national d'excellence en sante et en services sociaux (INESSS) [State of knowledge: considerations relating to the adoption of the learning health-care system approach, the reflective approach, and audit and feedback in the context of managing chronic diseases and multimorbid states]
2019     Institut national d'excellence en sante et en services sociaux (INESSS) [State of knowledge: smoking cessation strategies]
2019     Institut national d'excellence en sante et en services sociaux (INESSS) [Report: dose banding and dose rounding of antineoplastic agents]
2019     Institut national d'excellence en sante et en services sociaux (INESSS) [Report: intensive outpatient services for youths with psychoactive substance use disorders]
2019     Institut national d'excellence en sante et en services sociaux (INESSS) [Report: setting safety and conditions for success of vaginal birth after cesarean]
2019     Institut national d'excellence en sante et en services sociaux (INESSS) [State of practice: portrait of the Quebec adult trauma care network: 2013 – 2016]
2019     Institut national d'excellence en sante et en services sociaux (INESSS) [Report: relevance of low-dose computed tomography lung cancer screening]
2019     Institut national d'excellence en sante et en services sociaux (INESSS) [National medical protocols and associated prescriptions, updated in June 2019: unusual vaginal discharge]
2019     Institut national d'excellence en sante et en services sociaux (INESSS) [Organization of care and services for stroke to optimize access to endovascular treatment in Quebec]
2019     Institut national d'excellence en sante et en services sociaux (INESSS) [National medical protocols and associated prescriptions, updated in August 2020: pharmacological treatment of nausea in a person receiving palliative care]
2019     Institut national d'excellence en sante et en services sociaux (INESSS) [State of knowledge: mechanisms for accessing local services]
2019     Institut national d'excellence en sante et en services sociaux (INESSS) [Guidelines and standards: post-tick bite antibiotic prophylaxis to prevent Lyme disease, report in support of the knowledge transfer tools, the Québec’s national medical protocol and the collective prescription template]
2019     Institut national d'excellence en sante et en services sociaux (INESSS) [Report: the placenta, utility of and indications for the transfer of samples to the anatomical pathology laboratory for analysis]
2019     Institut national d'excellence en sante et en services sociaux (INESSS) [State of practice: withdrawal management in adult addiction rehabilitation service centres]
2019     Institut national d'excellence en sante et en services sociaux (INESSS) [Guidelines and standards: managing the risk of suicide and self-harm among youths living in rehabilitation centres for young persons with adjustment problems]
2019     Institut national d'excellence en sante et en services sociaux (INESSS) [Report: indications justifying the use of imaging for diagnosing patients with primary or secondary headache]
2019     Institut national d'excellence en sante et en services sociaux (INESSS) [National medical protocols and associated prescriptions, updated in October 2019: lipid-lowering pharmacologic agents]
2019     Institut national d'excellence en sante et en services sociaux (INESSS) [National medical protocols and associated prescriptions, updated in July 2019: high blood pressure]
2019     Institut national d'excellence en sante et en services sociaux (INESSS) [Report: HemlibraMC (emicizumab) - Hemophilia A, notice of inclusion on the Liste des produits du système du sang du Québec]
2019     Institut national d'excellence en sante et en services sociaux (INESSS) [Guidelines and standards, updated on May 4th 2020 : guide to preventing and treating chemotherapy or radiotherapy-induced nausea and vomiting in adults]
2019     Institut national d'excellence en sante et en services sociaux (INESSS) [National medical protocols and associated prescriptions, updated June 2019: palliative care - fever]
2019     Institut national d'excellence en sante et en services sociaux (INESSS) [State of knowledge: assessing the senior care and services continuum, prospects for measurement development]
2019     Institut national d'excellence en sante et en services sociaux (INESSS) [Report: Esperoct (turoctocog alfa pegol) – Hemophilia A, notice of inclusion on the Liste des produits du système du sang du Québec]
2019     Institut national d'excellence en sante et en services sociaux (INESSS) [State of knowledge: effects of assistance dogs and companion animals on persons with autism spectrum disorder or post-traumatic stress disorder]
2019     Institut national d'excellence en sante et en services sociaux (INESSS) [National medical protocols and associated prescriptions, updated in June 2019: urethral discharge]
2019     Institut national d'excellence en sante et en services sociaux (INESSS) [National medical protocols and associated prescriptions, updated in June 2019: acute exacerbations of chronic obstructive pulmonary disease (AECOPD)]
2019     Institut national d'excellence en sante et en services sociaux (INESSS) [Localized and disseminated stages of Lyme disease: from diagnosis to treatment, report in support of the diagnosis and treatment decision support tools]
2019     Institut national d'excellence en sante et en services sociaux (INESSS) [Report: assessment of the relevance of newborn blood spot screening for biotinidase deficiency (BIOT)]
2019     Institut national d'excellence en sante et en services sociaux (INESSS) [Report: Cutaquig, preparation of human immunoglobulins, notice of inclusion on the Liste des produits du système du sang du Québec]
2019     Institut national d'excellence en sante et en services sociaux (INESSS) [Report: axicabtagene ciloleucel for the treatment of relapsed or refractory large B-cell lymphoma]
2019     Institut national d'excellence en sante et en services sociaux (INESSS) [Guidelines and standards: autonomy in intellectually disabled young people aged 6 to 21 years]
2019     Institut national d'excellence en sante et en services sociaux (INESSS) [National medical protocols and associated prescriptions: antidiabetics]
2019     Institut national d'excellence en sante et en services sociaux (INESSS) [National medical protocols and associated prescriptions: anticoagulant therapy]
2019     Institut national d'excellence en sante et en services sociaux (INESSS) [State of knowledge, state of practice: Use of direct oral anticoagulants and warfarin in the context of atrial fibrillation and venous thromboembolism]
2019     Institut national d'excellence en sante et en services sociaux (INESSS) [Report: Alphanate - von Willebrand disease]
2019     Ontario Health Minimally invasive glaucoma surgery: a budget impact analysis and evaluation of patients’ experiences, preferences, and values
2019     Ontario Health Flash Glucose Monitoring System for People with Type 1 or Type 2 Diabetes: A Health Technology Assessment
2019     Ontario Health Osseointegrated Prosthetic Implants for People With Lower-Limb Amputation: A Health Technology Assessment
2019     Health Quality Ontario (HQO) Internet-Delivered Cognitive Behavioural Therapy for Major Depression and Anxiety Disorders: A Health Technology Assessment
2019     Health Quality Ontario (HQO) Perspectives of Pregnant People and Clinicians on Noninvasive Prenatal Testing: A Systematic Review and Qualitative Meta-synthesis
2019     Health Quality Ontario (HQO) Noninvasive Prenatal Testing for Trisomies 21, 18, and 13, Sex Chromosome Aneuploidies, and Microdeletions: A Health Technology Assessment
2019     Technology Assessment at SickKids (TASK) A cost-utility analysis of biosimilar infliximab compared to reference infliximab in adult switch patients with Crohn’s disease: a Canadian analysis
2019     Technology Assessment at SickKids (TASK) The economic evaluation of early intervention with anti-tumor necrosis factor-α treatments in pediatric Crohn's disease
2019     Technology Assessment at SickKids (TASK) A microcosting and cost-consequence analysis of genomic testing strategies (including trios) in autism spectrum disorder: an update
2019     Health Quality Ontario (HQO) Cervical Artificial Disc Replacement Versus Fusion for Cervical Degenerative Disc Disease: A Health Technology Assessment
2019     Health Quality Ontario (HQO) Compression Stockings for the Prevention of Venous Leg Ulcer Recurrence: A Health Technology Assessment
2019     Health Quality Ontario (HQO) Intermittent Catheters for Chronic Urinary Retention: A Health Technology Assessment
2018     Institut universitaire de cardiologie et de pneumologie de Québec – Université Laval (IUCPQ-ULaval) [Evaluation of the ultrasonic flowmeter for verification of graft patency during coronary artery bypass grafting]
2018     Institut universitaire de cardiologie et de pneumologie de Québec – Université Laval (IUCPQ-ULaval) [Evaluation of ambulatory electrocardiography technologies for the diagnosis of cardiac arrhythmia]
2018     Canadian Agency for Drugs and Technologies in Health (CADTH) Interventions for temporomandibular joint disorder: an overview of systematic reviews
2018     Canadian Agency for Drugs and Technologies in Health (CADTH) Clinical evaluation of interventions for the management of insomnia: a review of reviews
2018     Canadian Agency for Drugs and Technologies in Health (CADTH) Screening for chlamydia trachomatis and neisseria gonorrhoeae during pregnancy: a health technology assessment
2018     Canadian Agency for Drugs and Technologies in Health (CADTH) Metastatic melanoma gap analysis
2018     Canadian Agency for Drugs and Technologies in Health (CADTH) Drugs for the management of rheumatoid arthritis: clinical evaluation
2018     Canadian Agency for Drugs and Technologies in Health (CADTH) Composite resin versus amalgam for dental restorations: a health technology assessment
2018     Canadian Agency for Drugs and Technologies in Health (CADTH) Optimal strategies for the diagnosis of acute pulmonary embolism: a health technology assessment
2018     Centre intégré universitaire de santé et de services sociaux de la Capitale-Nationale (CIUSSS) [Best practices to reduce medication administration errors (MAEs) in hospital centre (HC) and long term care facilities centre (LTCF)]
2018     Institut national d'excellence en sante et en services sociaux (INESSS) [Report: use of clinical data from electronic medical records for research and continuous quality improvement in front-line care and services]
2018     Institut national d'excellence en sante et en services sociaux (INESSS) [State of practice in pediatric trauma care: patients admitted to the designated facilities of the trauma care network between 2010 and 2015]